We investigated the incidence, factors affecting referral and outcome of acute renal failure (ARF), in an unselected (predominantly Caucasian) population in the Grampian region of Scotland served by a single renal unit. Case-notes were examined for all patients with a serum creatinine ^ 300 uxnol/l. ARF (311 patients) was defined as a temporary rise in serum creatinine ^ 300 |imol/l, or, if the patient died during the acute illness, clinical features indicating acute deterioration of previously normal renal function. Advanced ARF at presentation (51 of the 311 with ARF) was defined as a first recorded serum creatinine ^ 500 (imol/l. Patients were classified into low-, medium-and high-risk groups according to presence of comorbidity and age. The annual incidence of ARF was 620/million population (pmp), that of advanced ARF 102 pmp. The age-related incidence of ARF ranged from 30 pmp in the age group (0-19 years) to 4266 pmp in the age group > 8 0 years. Overall, 22% were referred to a nephrologist (34% after excluding those with advanced cancer and age > 8 0 years). Referral of patients decreased from 100% in the age group 0-19 to 5% in those > 8 0 years. Referrals in the low-, medium-and high-risk groups were 75%, 30% and 14%, respectively. Patient survival at 2 years was 80%, 42% and 19% for low-, medium-and high-risk groups, respectively (86%, 44% and 32% for referred patients). Referral and outcome in patients with ARF were significantly influenced by age and presence of comorbidity at presentation.
Introduction
Community-based studies have estimated an incidence of advanced acute renal failure in the UK (serum creatinine ^500u.mol/l) of 140 per million of the population 1 and more than 50% of such patients are not referred to a nephrologist. 1 Studies based on data from renal units, therefore, provide an underestimate of the true incidence of ARF. and do not allow factors influencing referral of such patients to nephrologists to be examined. 2 ' 3 Community-based 1 ' 4 studies, although providing true incidence rates, have not studied patterns of referral to nephrology services in detail. We and others have previously shown 5 " 7 that comorbidity and age have a major influence on survival of patients with chronic renal failure and also on the referral of such patients to a nephrologist. 8 Using similar methods, we aimed to establish the incidence of ARF (serum creatininê 3 0 0 jimol/l) in an unselected population served by a single renal unit, and the factors affecting referral of these patients to a nephrologist.
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Hospitals NHS Trust and the results were stored on computer. Case-notes of all patients with a serum creatinine concentration ^300(j.mol/l were examined 2 years after the date of the assay. Acute renal failure was defined as a rise in serum creatinine concentration for the first time above 300 jamol/l, following which either (i) the serum creatinine returned to below that level and remained at a lower level, or returned to normal or (ii) the patient died during the acute illness and the clinical features were suggestive of acute deterioration (the patient previously having had normal renal function). Patients who had only one serum creatinine measurement were considered to have had acute renal failure if the clinical features suggested an acute illness, and they had died or were discharged without a further serum creatinine estimation. Such patients could include those with late presentation of end-stage renal disease and are therefore difficult to classify; they were included only if the clinicians regarded them as having had acute renal failure. Patients with an acute deterioration in renal function during the course of known chronic renal failure (creatinine persistently ^2 0 0 umol/l) and those who remained dialysis-dependent for more than 90 days after commencing renal replacement therapy were excluded from this study. The so called '90 day rule' is arbitrary and was used as a cut-off for defining acute renal failure. Patients who subsequently recovered renal function were regarded as having had acute renal failure. Patients whose first measured serum creatinine was ^5 0 0 (imol/l were classified as presenting with advanced ARF. The following information was extracted from case-notes: age and sex, dates of creatinine assays, date of referral to a nephrologist, cause of ARF, antecedent comorbidity at presentation, date of death and date of first dialysis if applicable. Each patient was assigned a risk category of low, medium or high, based on age and comorbidity at presentation ( Table 1 ). The age-related annual incidence of ARF was calculated using data from the report of the Registrar General of Scotland, 1990 which provided information on population in different age bands.
Statistics
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Yates' correction was used to compare discreet variables. Continuous data were compared using Mann-Whitney U and Student's t test. The level of significance was set at 5% for all comparisons.
Results
During the 12-month period 311 patients were identified who fulfilled the criteria for ARF as defined above. Complete data were available for 310 patients (malerfemale ratio 1.23). Of these, 51 patients (male: female ratio 2.4) presented with advanced ARF (creatinine at presentation ^5 0 0 uxnol/l). Overall 70/310 (22%) patients were referred to a nephrologist (35% of those with advanced ARF); when those with malignant disease and age above 80 years were excluded, the referral rate for the remainder rose to 34.2%. The mean age (95% Cl) was 72.3 (70.4-74.2) years for patients who were not referred to a nephrologist and 56.0 (51.3-60.7) for those who were referred (p<0.0001). The mean (95% Cl) ages in the low-, medium-and high-risk groups were 38.6 (28.5-48.7), 62.0 (58.9-64.9) and 74.6 (72.7-76.5) years, respectively. All 20 patients in the low-risk group were < 7 0 years and 45% of those in the high-risk group were > 8 0 years. Patients with volume depletion and cardiogenic shock were referred relatively infrequently (Table 2) .
Referral and survival according to risk group
Significantly more patients in the low-risk group were referred (75%) compared with those in the medium-and high-risk groups (30% and 14%, respectively, Table 3 ). Overall survival at 2 years was 80%, 46% and 19% in low-, medium-and high-risk groups, respectively (80%, 5 1 % and 32% at 3 months) ( Table 4) . Survival for those referred was 86% in the low-risk, 44% in the medium-risk and 32% in the high-risk group, and for those not referred Advanced ARF* 
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*Creatinine ^5 0 0 u,mol/l. Numbers in parentheses are patients referred to a nephrologist. 
Dialysis treatment
A total of 25 patients (50 per million/year) received dialysis, seven, eight and 10 in the low-, mediumand high-risk groups, respectively. Two-year survival in these patients was 7 1 % , 25% and 20%, in the low-, medium-and high-risk groups, respectively. 
Advanced ARF
Fifty-one patients presented with a serum creatininê 500uxnol/l. Intrinsic renal disease and urinary obstruction (both prostatic and non-prostatic) were the two main causes of renal failure in these patients ( Table 2 ). Referral was 7 1 % , 38% and 27%, in the low-, medium-and high-risk groups, respectively. Overall, 47% survived at 2 years (85% of the low-, 64% of the medium-and 30% of the high-risk group).
Annual incidence of ARF
After excluding those with a history of visceral malignant disease and those over 80 years, the incidence was 318/million. The annual incidence of ARF (creatinine ^3 0 0 u m o l / l ) was 620/million population and that of advanced ARF (creatininê 5 0 0 u.mol/1) was 102/million. The incidence of ARF increased with advancing age from 30/mi 11 ion/year for the age group 0-19 years to 4266/mil lion/year for those over the age of 80 years (excluding those with malignant disease) ( Table 5 ). Referral of patients decreased from 100% in the age group 0-19 years to only 5% in thosê 8 0 years.
Discussion
In this study, age and comorbidity had a major influence on referral to a nephrologist of patients with ARF. There is no agreed definition of ARF, which has made it difficult to compare results from different studies. We chose a definition based on clinical evidence of acute deterioration of renal function in patients with no evidence of renal failure prior to presentation and, in order accurately to define the incidence of ARF, we have excluded patients with acute deterioration of renal function during the course of known chronic renal insufficiency. We have also excluded patients with acute renal failure who remained dialysis-dependent for longer than 90 days, who were thus considered as having end-stage renal disease. Such patients, for whom the term 'acute irreversible renal failure' has been coined, may comprise almost 17% of those presenting with acute renal failure. 9 Our study, however, underestimated the true incidence of ARF in the community, as only those patients whose serum biochemistry had been measured could be studied. Previous studies of the incidence and outcome of ARF, both renal-unit-based and community-based, have shown a high mortality for this condition. 10 ' 11 It is difficult to compare the incidence of ARF in our study with those previously published, as we have aimed to define the incidence of patients with a serum creatinine at presentation of 300 u.mol/1. Feest et al. studied the incidence of advanced ARF (creatinine > 5 0 0 u.mol/1) and found an incidence of 140 per million. 1 The incidence of advanced ARF (creatinine at presentation 500jamol/l) in our study was 102 per million. This study has shown the major influence of antecedent comorbidity and advancing age on nephrology referral and survival. These two factors had an overriding influence on survival, irrespective of referral to a nephrologist. Survival was significantly better in the referred patients in the high-risk group. It can be speculated that non-referral of high-risk patients was appropriate in view of the presence of severe comorbidity. Whether improved survival in the referred high-risk patients was related to nephrology referral, cannot be determined, due to the retrospective and uncontrolled nature of the study. The 25 patients who received dialysis treatment (50/million of the population) had an overall survival of 64%. In these patients survival was best in low-risk (71%) and worst in the high-risk patients (20%). Thus overall crude mortality figures mask the influence of comorbidity on survival. We did not record the reasons for not offering dialysis to patients, as these data are difficult to obtain reliably, working retrospectively from case-notes.
There are no agreed guidelines for referral of patients to a nephrologist. Formulating such referral guidelines might save considerable time and resources if 'inappropriate' referrals, such as patients with transient rises of serum creatinine due to readily reversible disorders (e.g. volume depletion) or those with terminal renal failure in the course of advanced malignant disease, are avoided. Secondly those patients with intrinsic renal disease, or those with multi-organ failure, who might benefit most from nephrology referral, could be referred early in the course of ARF, which might improve outcome. Guidelines for the initial management of ARF (such as the need for ultrasound, serum and urinary osmolality, urine microscopy) may also help physicians determine the need for nephrology referral.
The incidence of ARF increases dramatically in the older age groups, and in this study the annual incidence increased from 30 per million in the age group 0-19 to 5188 per million in those over 80 years of age. There was a marked reduction in referral rates for older patients, decreasing from 44% for the age group 20-49 years to 19% for those aged 70-79, and only 5% for those > 80 years of age Only 22% of patients with ARF (as defined in this study) were referred to a nephrologist. The survival of patients referred in the high-risk group was better than those not referred and for all patients, comorbidity and age had a major influence on referral and survival. Guidelines for nephrology referral in this condition might help identify patients who might benefit from renal services. Increased referral of patients, however, is likely to require increased resources.
